2021 -now Associate Editor, Cardiovascular and Hematologic Drugs @ Frontiers in Drug Discovery
2022 -2025 Independent Board Member @
2017 -2021 Chief Medical Officer @
2019 -2021 Board Observer @ Tiburio Therapeutics
2019 -2019 Acting Chief Medical Officer @ Tiburio Therapeutics
2017 -2019 Acting Chief Medical Officer @ Imara Therapeutics
2013 -2016 Chief Medical Officer @
2009 -2013 Translational Medicine @
2001 -2009 Physician, Heart Failure and Transplantation Cardiology @
1999 -2001 Resident Physician @
Shi Foo Education
Harvard-MIT Health Sciences and Technology
MMSc (Clinical Investigator)
2007-2009
Stanford University School of Medicine
MD, PhD (Immunology, oncology)
Princeton University
BA (Molecular, Cellular and Developmental Biology)
Shi Foo Skills
Clinical Development
Clinical Research
Translational Medicine
Immunology
Clinical Trials
Cardiology
Genetics
Drug Development
Pharmaceutical Industry
Biotechnology
Translational Research
Stem Cells
Pharmacology
Biomarkers
Drug Discovery
Oncology
Transplant
Lifesciences
Life Sciences
Clinical Pharmacology
Inflammation
Cancer
Infectious Diseases
Medical Writing
Personalized Medicine
Project Management
Strategy
Management
Leadership
Medicine
Shi Foo Summary
Shi Foo, based in Cambridge, MA, US, is currently a Founder and CEO at Arvada Therapeutics. Shi Foo brings experience from previous roles at IsomAb Therapeutics, Prism Biolabs, Orchard Biomedical Consulting LLC and Frontiers in Drug Discovery. Shi Foo holds a 2007 - 2009 MMSc in Clinical Investigator @ Harvard-MIT Health Sciences and Technology. With a robust skill set that includes Clinical Development, Clinical Research, Translational Medicine, Immunology, Clinical Trials and more. Shi Foo has 1 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Shi Foo?
Find contact details for 700 million professionals.